loadpatents
name:-0.067722797393799
name:-0.1433789730072
name:-0.00054216384887695
CAI; Zhen-wei Patent Filings

CAI; Zhen-wei

Patent Applications and Registrations

Patent applications and USPTO patent grants for CAI; Zhen-wei.The latest application filed is for "novel neurokinin 1 receptor antagonist compounds ii".

Company Profile
0.25.27
  • CAI; Zhen-wei - Shanghai CN
  • Cai; Zhen-Wei - Belle Mead NJ US
  • Cai; Zhen-Wei - Belle Meade NJ
  • Cai, Zhen-Wei - Somerville NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Neurokinin 1 Receptor Antagonist Compounds Ii
App 20160207930 - BLADH; Haakan ;   et al.
2016-07-21
Substituted sulfonamides useful as antiapoptotic Bcl inhibitors
Grant 9,346,795 - Borzilleri , et al. May 24, 2
2016-05-24
4-pyridinone compounds and their use for cancer
Grant 8,754,230 - Livingston , et al. June 17, 2
2014-06-17
Substituted Sulfonamides Useful As Antiapoptotic Bcl Inhibitors
App 20140135318 - Borzilleri; Robert M. ;   et al.
2014-05-15
4-pyridinone Compounds And Their Use For Cancer
App 20140012007 - Livingston; Robert C. ;   et al.
2014-01-09
Pyridinone compounds
Grant 8,536,200 - Borzilleri , et al. September 17, 2
2013-09-17
Hydroxyphenyl sulfonamides as antiapoptotic bcl inhibitors
Grant 8,501,992 - Kim , et al. August 6, 2
2013-08-06
Alkyne-bridged Hetero-aromatics And Uses Thereof
App 20130158031 - CAI; Zhen-Wei ;   et al.
2013-06-20
4-pyridinone compounds and their use for cancer
Grant 8,258,118 - Borzilleri , et al. September 4, 2
2012-09-04
4-pyridinone Compounds And Their Use For Cancer
App 20120114643 - Borzilleri; Robert M. ;   et al.
2012-05-10
4-pyridinone compounds and their use for cancer
Grant 8,124,768 - Borzilleri , et al. February 28, 2
2012-02-28
Hydroxyphenyl Sulfonamides As Antiapoptotic Bcl Inhibitors
App 20110294793 - Kim; kyoung S ;   et al.
2011-12-01
4-pyridinone Compounds And Their Use For Cancer
App 20110295015 - Livingston; Robert C ;   et al.
2011-12-01
Pyridinone Compounds
App 20110052583 - Borzilleri; Robert M. ;   et al.
2011-03-03
4-pyridinone Compounds And Their Use For Cancer
App 20110034416 - Borzilleri; Robert M. ;   et al.
2011-02-10
Met kinase inhibitors
Grant 7,880,004 - Borzilleri , et al. February 1, 2
2011-02-01
Pyridinone compounds
Grant 7,851,489 - Borzilleri , et al. December 14, 2
2010-12-14
Inhibitors of kinases
Grant 7,820,814 - Bhide , et al. October 26, 2
2010-10-26
Bicyclic heterocycles as kinase inhibitors
Grant 7,566,784 - Borzilleri , et al. July 28, 2
2009-07-28
Novel Inhibitors Of Kinases
App 20090170853 - Bhide; Rajeev S. ;   et al.
2009-07-02
Heterocyclic inhibitors of kinases
Grant 7,547,711 - Borzilleri , et al. June 16, 2
2009-06-16
Inhibitors of kinases
Grant 7,521,450 - Bhide , et al. April 21, 2
2009-04-21
Fused heterocyclic kinase inhibitors
Grant 7,439,246 - Borzilleri , et al. October 21, 2
2008-10-21
Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
Grant 7,432,373 - Crispino , et al. October 7, 2
2008-10-07
Pyridinone Compounds
App 20080114033 - Borzilleri; Robert M. ;   et al.
2008-05-15
Pyrrolotriazine kinase inhibitors
Grant 7,348,325 - Cai , et al. March 25, 2
2008-03-25
Novel Inhibitors Of Kinases
App 20070299075 - Bhide; Rajeev S. ;   et al.
2007-12-27
Inhibitors of kinases
Grant 7,265,113 - Bhide , et al. September 4, 2
2007-09-04
Pyrrolotriazine kinase inhibitors
App 20070123534 - Cai; Zhen-Wei ;   et al.
2007-05-31
Met kinase inhibitors
App 20070117802 - Borzilleri; Robert M. ;   et al.
2007-05-24
Fused heterocyclic kinase inhibitors
App 20060211695 - Borzilleri; Robert M. ;   et al.
2006-09-21
Pyrrolotriazine kinase inhibitors
Grant 7,102,002 - Cai , et al. September 5, 2
2006-09-05
Heterocyclic inhibitors of kinases
Grant 7,084,160 - Borzilleri , et al. August 1, 2
2006-08-01
Heterocyclic inhibitors of kinases
App 20060135576 - Borzilleri; Robert M. ;   et al.
2006-06-22
Pyrrolotriazine kinase inhibitors
App 20060009454 - Cai; Zhen-wei ;   et al.
2006-01-12
Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
App 20050288289 - Crispino, Gerard ;   et al.
2005-12-29
Fused heterocyclic kinase inhibitors
App 20050288290 - Borzilleri, Robert M. ;   et al.
2005-12-29
Bicyclic heterocycles as kinase inhibitors
App 20050239820 - Borzilleri, Robert M. ;   et al.
2005-10-27
Process for preparing certain pyrrolotriazine compounds
Grant 6,933,386 - Bhide , et al. August 23, 2
2005-08-23
Novel inhibitors of kinases
App 20050124621 - Bhide, Rajeev S. ;   et al.
2005-06-09
Pyrrolo[2,1-f][1,2,4]triazine inhibitors of kinases
Grant 6,869,952 - Bhide , et al. March 22, 2
2005-03-22
Heterocyclic inhibitors of kinases
App 20040077696 - Borzilleri, Robert M. ;   et al.
2004-04-22
Process for preparing certain pyrrolotriazine compounds
App 20040077858 - Bhide, Rajeev S. ;   et al.
2004-04-22
Novel inhibitors of kinases
App 20040072832 - Bhide, Rajeev S. ;   et al.
2004-04-15
Aminothiazole inhibitors of cyclin dependent kinases
App 20020137778 - Kim, Kyoung S. ;   et al.
2002-09-26
Aminothiazole inhibitors of cyclin dependent kinases
Grant 6,262,096 - Kim , et al. July 17, 2
2001-07-17
Aminothiazole inhibitors of cyclin dependent kinases
Grant 6,040,321 - Kim , et al. March 21, 2
2000-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed